studi
sot
patient
becam
acut
infect
hepat
e
januari
june
infect
diagnos
detect
hev
rna
use
real
time
polymeras
chain
reaction
pcr
immunoglobulin
mimmunoglobulin
g
antihev
antibodi
commerci
enzymelink
immunosorb
assay
patient
assign
one
group
accord
outcom
infect
first
group
group
patient
chronic
infect
defin
persist
elev
liver
enzym
activ
serum
posit
hev
rna
month
diagnosi
second
group
group
ii
patient
resolv
infect
serum
sampl
collect
patient
acut
phase
infect
store
patient
underw
exhaust
clinic
laboratori
examin
includ
immunosuppress
drug
use
hepat
enzym
activ
white
blood
cell
count
serum
concentr
hev
rna
measur
realtim
pcr
viru
genotyp
determin
sequenc
fragment
within
gene
sequenc
compar
refer
hev
strain
genbank
describ
elsewher
nucleic
acid
extract
serum
sampl
analys
rtpcr
sens
primer
antisens
primer
use
super
script
iii
enzym
invitrogen
cergypontois
franc
sequenc
primer
list
supplementari
tabl
sequenc
amplifi
includ
ppr
nucleotid
nt
macro
domain
nt
use
genom
refer
pcr
product
purifi
use
qiaprep
qiagen
courtaboeuf
franc
miniprep
kit
store
total
ng
amplifi
sequenc
directli
ligat
pcr
vector
kit
topo
ta
clone
invitrogen
contain
gene
confer
resist
ampicillin
recombin
plasmid
use
transform
escherichia
colicompet
cell
transform
grown
ampicillinco
plate
hour
complementari
dna
cdna
clone
patient
sampl
analys
pcr
primer
supplementari
tabl
pcr
product
amplif
purifi
quickspin
column
qiagen
sequenc
use
fluoresc
dye
termin
method
big
dyetermin
cycl
sequenc
appli
biosystem
pari
franc
primer
supplementari
tabl
appli
biosystem
abi
xl
analyz
sequenc
align
use
clustal
x
compar
hev
strain
obtain
genbank
quantifi
complex
hev
quasispeci
calcul
shannon
entropi
pi
ln
pi
pi
frequenc
sequenc
viral
quasispeci
normal
entropi
nucleotid
aminoacid
sn
calcul
use
sn
sln
n
n
total
number
sequenc
analys
quantifi
divers
mean
genet
distanc
calcul
pair
nucleotid
sequenc
use
mega
number
synonym
ks
substitut
per
synonym
site
nonsynonym
ka
substitut
per
nonsynonym
site
calcul
jukescantor
correct
multipl
substitut
use
mega
kak
ratio
indic
posit
neg
select
pressur
quasispeci
proport
compar
fisher
exact
test
quantit
variabl
compar
nonparametr
test
correl
complex
divers
quasispeci
estim
calcul
spearman
rank
correl
coeffici
pvalu
consid
statist
signific
sequenc
deposit
genbank
databas
access
number
clinic
biolog
characterist
patient
summar
supplementari
tabl
signific
differ
patient
chronic
infect
resolv
infect
term
gender
age
immunosuppress
treatment
alt
activ
individu
chronic
infect
tend
lower
patient
whose
infect
becam
chronic
lower
total
lymphocyt
count
differ
signific
serum
hev
rna
concentr
acut
phase
group
patient
similar
infect
hev
genotyp
strain
except
one
whose
infect
genotyp
compar
sequenc
heterogen
region
patient
chronic
hev
infect
resolv
infect
mean
nucleotid
sequenc
entropi
nt
complex
ppr
higher
group
group
ii
p
similar
result
obtain
macro
domain
group
group
ii
p
figur
mean
aminoacid
aa
sequenc
entropi
aa
complex
ppr
significantli
higher
group
group
ii
p
similar
result
obtain
macro
domain
group
group
ii
p
figur
mean
pairwis
withinsampl
genet
distanc
divers
ppr
higher
group
group
ii
p
macro
domain
divers
also
greater
group
group
ii
p
figur
nt
complex
divers
ppr
posit
correl
macro
domain
r
p
r
p
respect
ratio
nonsynonym
substitut
per
nonsynonym
site
ka
synonym
substitut
per
synonym
site
ks
ppr
seem
higher
group
group
ii
differ
statist
signific
p
kak
ratio
macro
domain
group
group
ii
p
similar
shown
recent
hev
infect
evolv
chronic
infect
sot
recipi
viral
determin
associ
persist
infect
poorli
document
therefor
investig
influenc
genet
heterogen
hev
quasispeci
outcom
infect
focus
ppr
macro
domain
complex
divers
ppr
macro
domain
higher
viral
popul
patient
whose
infect
becam
chronic
clear
viru
shown
quasispeci
heterogen
region
encod
capsid
protein
acut
phase
infect
associ
develop
chronic
hev
infect
data
support
find
great
genet
heterogen
quasispeci
patient
whose
infect
becom
chronic
seem
favor
appear
variant
persist
report
hcv
infect
although
divers
region
preced
ppr
higher
patient
chronic
infect
nt
aa
complex
differ
group
data
shown
suggest
higher
heterogen
chronic
patient
gener
effect
seen
across
entir
region
studi
great
genet
heterogen
could
also
reflect
inadequ
control
viral
replic
correl
found
quasispeci
heterogen
viral
concentr
ppr
appear
dispens
vitro
hev
replic
requir
vivo
infect
suggest
involv
infect
cell
innat
immun
although
role
macro
domain
replic
hev
unknown
seem
essenti
replic
coronaviru
cell
cultur
recent
suggest
gene
dispens
viru
replic
involv
modul
host
immun
respons
like
downregul
interleukin
tumor
necrosi
factor
tnf
secret
macro
domain
also
involv
inflamm
caus
mous
hepat
viru
mhv
substitut
strictli
conserv
aminoacid
residu
respons
reduc
secret
inflammatori
cytokin
great
quasispeci
heterogen
patient
whose
infect
becam
chronic
may
includ
variant
reduc
inflammatori
cytokin
product
could
facilit
hev
persist
could
explain
lower
serum
concentr
interleukin
receptor
antagonist
found
patient
whose
infect
becam
chronic
find
complex
divers
ppr
macro
domain
correl
region
may
well
evolv
togeth
protein
encod
seem
cleav
also
studi
correl
studi
previou
one
divers
carri
patient
except
also
find
complex
divers
region
studi
correl
data
shown
suggest
evolv
togeth
final
find
differ
kak
ratio
studi
region
even
though
kak
ratio
ppr
seem
higher
patient
clear
viru
altern
kak
ratio
may
allow
us
infer
differ
select
pressur
region
kak
ratio
indic
neg
select
probabl
due
structur
function
constraint
limit
studi
small
number
patient
group
implic
immunolog
factor
evolut
toward
chronic
exclud
conclud
high
genet
heterogen
ppr
macro
domain
acut
phase
hev
infect
associ
persist
viru
associ
may
due
appear
mutant
abl
modul
host
immun
respons
investig
need
confirm
associ
